NCT00132431View on ClinicalTrials.gov

START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

July 31, 2005

Conditions
Kidney DiseaseSecondary HyperparathyroidismChronic Kidney Disease
Interventions
DRUG

Sensipar

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY